Ignite Creation Date:
2025-12-24 @ 12:31 PM
Ignite Modification Date:
2026-03-08 @ 4:26 AM
Study NCT ID:
NCT00415961
Status:
TERMINATED
Last Update Posted:
2009-01-09
First Post:
2006-12-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety
Sponsor:
Conor Medsystems
Organization:
Study Overview
Official Title:
Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety
Status:
TERMINATED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial aims to demonstrate the non-inferiority of the CI-CMS-005 Coronary Stent System to the study device as well as to the TAXUS™ Express2™ Drug-Eluting Coronary Stent System in in-segment late lumen loss at 9 months after treatment of a single de novo lesion per vessel.
Detailed Description:
This is a complementary, multi-center, open-label, single-arm trial investigating angiographic and clinical patient outcomes in Japan. Historical data from the 2-arm randomized COSTAR II trial will be used for comparison.
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: